Aelis Farma (XPAR:AELIS) OCF Margin %: 0.00% (As of Dec. 2025)


XPAR:AELIS Aelis Farma SA XPAR:AELIS
32 GF Score
Price €1.07
GF Value €0.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma OCF Margin %?

Aelis Farma XPAR:AELIS +5.94% 32 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates XPAR:AELIS with a GF Score™ of 32/100 and a GF Value™ of €0.98 (Fairly Valued). The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Aelis Farma ranks worse than 105596.52% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Aelis Farma's Cash Flow from Operations for the six months ended in Dec. 2025 was €-1.47 Mil. Aelis Farma's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Aelis Farma's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Aelis Farma's current OCF Yield % is -37.75%.

The historical rank and industry rank for Aelis Farma's OCF Margin % or its related term are showing as below:


During the past 9 years, the highest OCF Margin % of Aelis Farma was 209.04%. The lowest was -441.78%. And the median was -242.89%.

XPAR:AELIS's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -64.23
* Ranked among companies with meaningful OCF Margin % only.

Aelis Farma OCF Margin % Related Terms

Aelis Farma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Aelis Farma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma OCF Margin % Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only 209.04 -342.64 -143.13 -441.78 0.00

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -92.44 -366.35 -819.28 0.00 0.00
XPAR:AELIS
32GF Score
Aelis Farma SA XPAR:AELIS
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Aelis Farma's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.353/0
= %

Aelis Farma's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.47/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Aelis Farma (XPAR:AELIS) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aelis Farma and its competitors. According to the industry distribution chart, Aelis Farma ranks #999999 out of 947 companies in the Biotechnology industry.
Is Aelis Farma's OCF Margin % too high?
Aelis Farma's current OCF Margin % is 0.00%. Based on the distribution chart, Aelis Farma ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aelis Farma has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aelis Farma ranks #999999 out of 947 companies for OCF Margin %. This places Aelis Farma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aelis Farma and its competitors. Aelis Farma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Based on GuruFocus' analysis, Aelis Farma (XPAR:AELIS) is currently considered Fairly Valued. The stock's GF Value™ is €0.98, compared to a current price of €1.07 — trading 9.2% above its estimated fair value. The current OCF Margin % is 0.00%. Aelis Farma's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aelis Farma (XPAR:AELIS), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (XPAR:AELIS) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.07 is trading 9.2% above its estimated GF Value™ of €0.98. GuruFocus considers Aelis Farma to be Fairly Valued.

Key valuation signals for XPAR:AELIS:

  • OCF Margin %: 0.00%
  • GF Value™: €0.98 vs. price of €1.07 (9.2% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the XPAR:AELIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges 69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for XPAR:AELIS

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.07
Price
€0.98
GF Value